Search
BioRestorative Therapies Inc
BRTXAdd to Watchlist
1.490USD
-0.010-0.67%
Close 11-13 16:00（ET）
2.06MMarket Cap
LossP/E TTM
BioRestorative Therapies Inc (BRTX) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to BioRestorative Therapies Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
300.000USD+21323.98%
BRTX Analyst Recommendation Trends
In the current month, BRTX has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BRTX average Analyst price target in the last month is 300.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
BRTX Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, BRTX EPS is projected to reach -2.500 in FY2026Q2, following reported EPS of -2.431 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q3
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
Forecast
-7.20
-7.40
-4.00
-2.50
-2.00
Actual
-6.67
-0.33
-2.43
--
--
Surprise
+7.42%
+95.55%
+39.23%
--
--
FAQs
What is BioRestorative Therapies Inc's expected revenue for the next quarter?
BioRestorative Therapies Inc's expected revenue is 335.00K.
What is BioRestorative Therapies Inc's price target?
Analysts forecast that BioRestorative Therapies Inc's price target is USD 300.00, with the highest forecast at USD 300.00 and the lowest forecast at USD 300.00.
How have BioRestorative Therapies IncBRTX's recent earnings per share performed?
The market expectation was USD -2.43, while BioRestorative Therapies IncBRTX's earnings per share (EPS) for the previous quarter was USD -0.33. EPS for the next quarter is expected at USD -2.50.
What is the analyst rating for BioRestorative Therapies Inc?
Based on the ratings of BioRestorative Therapies Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.